5,422
edits
No edit summary |
No edit summary |
||
Line 25: | Line 25: | ||
[[CT]] thorax and abdomen is required for staging. [[Bronchoscopy]] is required if extension into the bronchial system is suspected. | [[CT]] thorax and abdomen is required for staging. [[Bronchoscopy]] is required if extension into the bronchial system is suspected. | ||
== Treatment == | == Treatment == | ||
Line 38: | Line 35: | ||
After surgical resection of the oesophagus, either total or partial, the resected part of the oesophagus should be substituted with stomach (first choice) or colon. Because of the localisation of the oesophagus, oesophageal surgery may involve the neck, thorax, and/or the abdomen, making for a large and complicated surgery. | After surgical resection of the oesophagus, either total or partial, the resected part of the oesophagus should be substituted with stomach (first choice) or colon. Because of the localisation of the oesophagus, oesophageal surgery may involve the neck, thorax, and/or the abdomen, making for a large and complicated surgery. | ||
Surgery may be performed open, laparoscopically, or in combination. | Surgery may be performed [[Laparotomy|open]], [[Laparoscopic surgery|laparoscopically]], or in combination. | ||
Locally advanced oesophageal cancer is treated with [[neoadjuvant]] chemoradiation, followed by surgery if the tumour is considered resectable on restaging. | Locally advanced oesophageal cancer is treated with [[neoadjuvant]] chemoradiation, followed by surgery if the tumour is considered resectable on restaging. | ||
[[Palliative therapy]] is often employed for stage IV disease. The placement of stents is the major palliative option for oesophageal cancer. | [[Palliative surgery|Palliative therapy]] is often employed for stage IV disease. The placement of stents is the major palliative option for oesophageal cancer. | ||
[[Category:Gastrointestinal surgery]] | == Prognosis == | ||
[[Category:Gastroenterology]] | The prognosis is very poor, with a 5-year survival of 15%. The 5-year survival of patients treated with curative surgery is around 30 – 40%. Squamous cell carcinoma has a worse prognosis than adenocarcinoma. | ||
<noinclude>[[Category:Gastrointestinal surgery]] | |||
[[Category:Gastroenterology]]</noinclude> |